Author Archives for Kristin Aldag

Tumor-LN-oC is on Zenodo!

April 19, 2023 8:37 am Published by Comments Off on Tumor-LN-oC is on Zenodo!

Tumor-LN-oC latest achievements, technical results and scientific outputs will be published on the Tumor-LN-oC community on Zenodo. The first two, recently published... View Article


PhosPrint selected as finalist for the SPIE Startup Challenge

December 12, 2022 2:21 pm Published by Comments Off on PhosPrint selected as finalist for the SPIE Startup Challenge

Our consortium partner PhosPrint was selected as one of the finalists of the 13th annual SPIE Startup Challenge! The final pitch presentations will take place at SPIE Photonics West in San Francisco on 31 January 2023.


M18 project meeting and first successful review

December 1, 2022 7:56 am Published by Comments Off on M18 project meeting and first successful review

After 1.5 years of project implementation, the Tumor-LN-oC consortium recently gathered in Athens for the M18 project meeting. The 2-day consortium meeting was followed by the first periodic review meeting.


Laser bioprinting: a key technology for recapitulating tissue and cell functions

April 12, 2022 12:09 pm Published by Comments Off on Laser bioprinting: a key technology for recapitulating tissue and cell functions

As one of the components of the Tumor-LN-oC platform, consortium partner PhosPrint is working on a laser bioprinting process for OrganOnChip (OoC) and sensor applications. PhosPrint representative Simos Papazoglou presented the project progress at SPIE Photonics Europe last week.


Tumor-LN-oC completes selection of materials and processes

March 24, 2022 2:58 pm Published by Comments Off on Tumor-LN-oC completes selection of materials and processes

With the conclusion of Month 10 of the project, Tumor-LN-oC consortium successfully passed the second milestone of the project: the final selection of specifications for materials, processes and user requirements.